Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: the multi-ethnic study of atherosclerosis

[1]  D. Jędrzejuk,et al.  Left Ventricular Function Impairment in Patients With Normal-Weight Obesity: Contribution of Abdominal Fat Deposition, Profibrotic State, Reduced Insulin Sensitivity, and Proinflammatory Activation , 2012, Circulation. Cardiovascular imaging.

[2]  M. Benito,et al.  Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction. , 2012, Endocrinology.

[3]  C. Bouchard,et al.  Bariatric surgery and long-term cardiovascular events. , 2012, JAMA.

[4]  J. J. Rivera,et al.  The relationship of insulin resistance and extracoronary calcification in the multi-ethnic study of atherosclerosis. , 2011, Atherosclerosis.

[5]  C. Stefanadis,et al.  Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. , 2011, Journal of the American College of Cardiology.

[6]  H. Bays.  Adiposopathy is "sick fat" a cardiovascular disease? , 2011, Journal of the American College of Cardiology.

[7]  C. Torp‐Pedersen,et al.  Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. , 2011, Journal of the American College of Cardiology.

[8]  Shantanu Sinha,et al.  Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (multi-ethnic study of atherosclerosis). , 2011, Journal of the American College of Cardiology.

[9]  C. Apovian,et al.  Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. , 2009, Journal of the American College of Cardiology.

[10]  D. Bluemke,et al.  Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA). , 2011, International journal of molecular epidemiology and genetics.

[11]  L. Luzi,et al.  Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals , 2010, Diabetes Care.

[12]  A. Rudich,et al.  Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation. , 2010, Endocrinology.

[13]  Yongmei Liu,et al.  Inflammatory Markers and Incident Heart Failure Risk in Older Adults: The Health, Aging, and Body Composition Study , 2009 .

[14]  C. Fox,et al.  Relations of Insulin Resistance and Glycemic Abnormalities to Cardiovascular Magnetic Resonance Measures of Cardiac Structure and Function: The Framingham Heart Study , 2010, Circulation. Cardiovascular imaging.

[15]  R. Kronmal,et al.  The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2010, JACC. Cardiovascular imaging.

[16]  P. Pellikka,et al.  Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. , 2010, The American journal of cardiology.

[17]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[18]  E. Ingelsson,et al.  Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men , 2010, Circulation.

[19]  G. Norton,et al.  Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity. , 2009, The American journal of cardiology.

[20]  G. Paolisso,et al.  Role of Subcutaneous Abdominal Fat on Cardiac Function and Proinflammatory Cytokines in Premenopausal Obese Women , 2009, Annals of plastic surgery.

[21]  M. Whooley,et al.  Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study). , 2009, The American journal of cardiology.

[22]  B. Sobel,et al.  A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart , 2009, Experimental biology and medicine.

[23]  David A Bluemke,et al.  The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. , 2008, Journal of the American College of Cardiology.

[24]  Matthew G. Johnson,et al.  Central obesity: association with left ventricular dysfunction and mortality in the community. , 2008, American heart journal.

[25]  R. Kronmal,et al.  Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. , 2008, Journal of the American College of Cardiology.

[26]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[27]  T. Marwick,et al.  Alterations in myocardial characteristics associated with obesity: detection, mechanisms, and implications. , 2007, Trends in cardiovascular medicine.

[28]  T. Marwick,et al.  Obesity cardiomyopathy: pathogenesis and pathophysiology , 2007, Nature Clinical Practice Cardiovascular Medicine.

[29]  D. Bluemke,et al.  Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. , 2006, Journal of the American College of Cardiology.

[30]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[31]  M. Szklo,et al.  Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2006, Diabetes care.

[32]  R. Kronmal,et al.  Left Ventricular Concentric Remodeling Is Associated With Decreased Global and Regional Systolic Function: The Multi-Ethnic Study of Atherosclerosis , 2005, Circulation.

[33]  S. Reis,et al.  Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) Study , 2004, Circulation.

[34]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[35]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[36]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.